カテゴリー： QYResearch, 世界, 医療/バイオ

エキスポーチン1のグローバル市場2023年：染色体領域維持1蛋白質ホモログ、XPO1

◆英語タイトル：Global Exportin 1 Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA8755）◆商品コード：QYR23MA8755
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月
◆ページ数：91
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界のエキスポーチン1市場について調査・分析し、世界のエキスポーチン1市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（染色体領域維持1蛋白質ホモログ、XPO1）、用途別セグメント分析（がん、中枢神経系、免疫、遺伝子疾患、感染症）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Biogen Inc、CanBas Co Ltd、Jiangsu Carephar Pharmaceutical Co Ltd、Karyopharm Therapeutics Inc、Oita University Institute of Advanced Medicine Inc、Wigen Biomedicine Technology (Shanghai) Co Ltdなどが含まれています。世界のエキスポーチン1市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、エキスポーチン1市場規模を推定する際に考慮しました。

・エキスポーチン1市場の概要
- 製品の定義
- エキスポーチン1のタイプ別セグメント
- 世界のエキスポーチン1市場規模：タイプ別分析（染色体領域維持1蛋白質ホモログ、XPO1）
- エキスポーチン1の用途別セグメント
- 世界のエキスポーチン1市場規模：用途別分析（がん、中枢神経系、免疫、遺伝子疾患、感染症）
- 世界のエキスポーチン1市場規模予測（2018年-2029年）
- エキスポーチン1の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- エキスポーチン1市場の競争状況およびトレンド

・エキスポーチン1の地域別市場規模
- 北米のエキスポーチン1市場規模（2018年-2029年）
- アメリカのエキスポーチン1市場規模（2018年-2029年）
- ヨーロッパのエキスポーチン1市場規模（2018年-2029年）
- アジア太平洋のエキスポーチン1市場規模（2018年-2029年）
- 中国のエキスポーチン1市場規模（2018年-2029年）
- 日本のエキスポーチン1市場規模（2018年-2029年）
- 韓国のエキスポーチン1市場規模（2018年-2029年）
- インドのエキスポーチン1市場規模（2018年-2029年）
- オーストラリアのエキスポーチン1市場規模（2018年-2029年）
- 中南米のエキスポーチン1市場規模（2018年-2029年）
- 中東・アフリカのエキスポーチン1市場規模（2018年-2029年）

・タイプ別セグメント：染色体領域維持1蛋白質ホモログ、XPO1
- 世界のエキスポーチン1のタイプ別販売量（2018年-2023年）
- 世界のエキスポーチン1のタイプ別売上（2018年-2023年）
- 世界のエキスポーチン1のタイプ別価格

・用途別セグメント：がん、中枢神経系、免疫、遺伝子疾患、感染症
- 世界のエキスポーチン1の用途別販売量（2018年-2023年）
- 世界のエキスポーチン1の用途別売上（2018年-2023年）
- 世界のエキスポーチン1の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Biogen Inc、CanBas Co Ltd、Jiangsu Carephar Pharmaceutical Co Ltd、Karyopharm Therapeutics Inc、Oita University Institute of Advanced Medicine Inc、Wigen Biomedicine Technology (Shanghai) Co Ltd

・産業チェーンと販売チャネルの分析
- エキスポーチン1産業チェーン分析
- エキスポーチン1の主要原材料
- エキスポーチン1の販売チャネル
- エキスポーチン1のディストリビューター
- エキスポーチン1の主要顧客

・エキスポーチン1市場ダイナミクス
- エキスポーチン1の業界動向
- エキスポーチン1市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) – Exportin 1 (XPO1) or chromosomal maintenance 1 (CRM1) is a eukaryotic protein. It mediates the nuclear export of cellular proteins bearing a leucine-rich nuclear export signal (NES) and of RNAs. In association with RANBP3, it binds cooperatively to the NES on its target protein and to the GTPase RAN in its active Ran-GTP. Docking of this complex to the nuclear pore complex (NPC) is mediated through binding to nucleoporins. It is involved in U3 snoRNA transport from Cajal bodies to nucleoli. The molecules developed by companies in Pre-Registration, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 1, 3, 1, 3 and 1 respectively.
Highlights
The global Exportin 1 market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Exportin 1 is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Exportin 1 is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Exportin 1 include Biogen Inc, CanBas Co Ltd, Jiangsu Carephar Pharmaceutical Co Ltd, Karyopharm Therapeutics Inc, Oita University Institute of Advanced Medicine Inc and Wigen Biomedicine Technology (Shanghai) Co Ltd, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Exportin 1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exportin 1.
The Exportin 1 market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Exportin 1 market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exportin 1 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Biogen Inc
CanBas Co Ltd
Jiangsu Carephar Pharmaceutical Co Ltd
Karyopharm Therapeutics Inc
Oita University Institute of Advanced Medicine Inc
Wigen Biomedicine Technology (Shanghai) Co Ltd
Segment by Type
Chromosome Region Maintenance 1 Protein Homolog
XPO1
Segment by Application
Oncology
Central Nervous System
Immunology
Genetic Disorders
Infectious Disease
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Exportin 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Exportin 1 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Exportin 1 Market Overview
1.1 Product Overview and Scope of Exportin 1
1.2 Exportin 1 Segment by Type
1.2.1 Global Exportin 1 Market Value Comparison by Type (2023-2029)
1.2.2 Chromosome Region Maintenance 1 Protein Homolog
1.2.3 XPO1
1.3 Exportin 1 Segment by Application
1.3.1 Global Exportin 1 Market Value by Application: (2023-2029)
1.3.2 Oncology
1.3.3 Central Nervous System
1.3.4 Immunology
1.3.5 Genetic Disorders
1.3.6 Infectious Disease
1.4 Global Exportin 1 Market Size Estimates and Forecasts
1.4.1 Global Exportin 1 Revenue 2018-2029
1.4.2 Global Exportin 1 Sales 2018-2029
1.4.3 Global Exportin 1 Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Exportin 1 Market Competition by Manufacturers
2.1 Global Exportin 1 Sales Market Share by Manufacturers (2018-2023)
2.2 Global Exportin 1 Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Exportin 1 Average Price by Manufacturers (2018-2023)
2.4 Global Exportin 1 Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Exportin 1, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Exportin 1, Product Type & Application
2.7 Exportin 1 Market Competitive Situation and Trends
2.7.1 Exportin 1 Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Exportin 1 Players Market Share by Revenue
2.7.3 Global Exportin 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Exportin 1 Retrospective Market Scenario by Region
3.1 Global Exportin 1 Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Exportin 1 Global Exportin 1 Sales by Region: 2018-2029
3.2.1 Global Exportin 1 Sales by Region: 2018-2023
3.2.2 Global Exportin 1 Sales by Region: 2024-2029
3.3 Global Exportin 1 Global Exportin 1 Revenue by Region: 2018-2029
3.3.1 Global Exportin 1 Revenue by Region: 2018-2023
3.3.2 Global Exportin 1 Revenue by Region: 2024-2029
3.4 North America Exportin 1 Market Facts & Figures by Country
3.4.1 North America Exportin 1 Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Exportin 1 Sales by Country (2018-2029)
3.4.3 North America Exportin 1 Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Exportin 1 Market Facts & Figures by Country
3.5.1 Europe Exportin 1 Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Exportin 1 Sales by Country (2018-2029)
3.5.3 Europe Exportin 1 Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Exportin 1 Market Facts & Figures by Country
3.6.1 Asia Pacific Exportin 1 Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Exportin 1 Sales by Country (2018-2029)
3.6.3 Asia Pacific Exportin 1 Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Exportin 1 Market Facts & Figures by Country
3.7.1 Latin America Exportin 1 Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Exportin 1 Sales by Country (2018-2029)
3.7.3 Latin America Exportin 1 Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Exportin 1 Market Facts & Figures by Country
3.8.1 Middle East and Africa Exportin 1 Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Exportin 1 Sales by Country (2018-2029)
3.8.3 Middle East and Africa Exportin 1 Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Exportin 1 Sales by Type (2018-2029)
4.1.1 Global Exportin 1 Sales by Type (2018-2023)
4.1.2 Global Exportin 1 Sales by Type (2024-2029)
4.1.3 Global Exportin 1 Sales Market Share by Type (2018-2029)
4.2 Global Exportin 1 Revenue by Type (2018-2029)
4.2.1 Global Exportin 1 Revenue by Type (2018-2023)
4.2.2 Global Exportin 1 Revenue by Type (2024-2029)
4.2.3 Global Exportin 1 Revenue Market Share by Type (2018-2029)
4.3 Global Exportin 1 Price by Type (2018-2029)
5 Segment by Application
5.1 Global Exportin 1 Sales by Application (2018-2029)
5.1.1 Global Exportin 1 Sales by Application (2018-2023)
5.1.2 Global Exportin 1 Sales by Application (2024-2029)
5.1.3 Global Exportin 1 Sales Market Share by Application (2018-2029)
5.2 Global Exportin 1 Revenue by Application (2018-2029)
5.2.1 Global Exportin 1 Revenue by Application (2018-2023)
5.2.2 Global Exportin 1 Revenue by Application (2024-2029)
5.2.3 Global Exportin 1 Revenue Market Share by Application (2018-2029)
5.3 Global Exportin 1 Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Biogen Inc
6.1.1 Biogen Inc Corporation Information
6.1.2 Biogen Inc Description and Business Overview
6.1.3 Biogen Inc Exportin 1 Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Biogen Inc Exportin 1 Product Portfolio
6.1.5 Biogen Inc Recent Developments/Updates
6.2 CanBas Co Ltd
6.2.1 CanBas Co Ltd Corporation Information
6.2.2 CanBas Co Ltd Description and Business Overview
6.2.3 CanBas Co Ltd Exportin 1 Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CanBas Co Ltd Exportin 1 Product Portfolio
6.2.5 CanBas Co Ltd Recent Developments/Updates
6.3 Jiangsu Carephar Pharmaceutical Co Ltd
6.3.1 Jiangsu Carephar Pharmaceutical Co Ltd Corporation Information
6.3.2 Jiangsu Carephar Pharmaceutical Co Ltd Description and Business Overview
6.3.3 Jiangsu Carephar Pharmaceutical Co Ltd Exportin 1 Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Jiangsu Carephar Pharmaceutical Co Ltd Exportin 1 Product Portfolio
6.3.5 Jiangsu Carephar Pharmaceutical Co Ltd Recent Developments/Updates
6.4 Karyopharm Therapeutics Inc
6.4.1 Karyopharm Therapeutics Inc Corporation Information
6.4.2 Karyopharm Therapeutics Inc Description and Business Overview
6.4.3 Karyopharm Therapeutics Inc Exportin 1 Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Karyopharm Therapeutics Inc Exportin 1 Product Portfolio
6.4.5 Karyopharm Therapeutics Inc Recent Developments/Updates
6.5 Oita University Institute of Advanced Medicine Inc
6.5.1 Oita University Institute of Advanced Medicine Inc Corporation Information
6.5.2 Oita University Institute of Advanced Medicine Inc Description and Business Overview
6.5.3 Oita University Institute of Advanced Medicine Inc Exportin 1 Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Oita University Institute of Advanced Medicine Inc Exportin 1 Product Portfolio
6.5.5 Oita University Institute of Advanced Medicine Inc Recent Developments/Updates
6.6 Wigen Biomedicine Technology (Shanghai) Co Ltd
6.6.1 Wigen Biomedicine Technology (Shanghai) Co Ltd Corporation Information
6.6.2 Wigen Biomedicine Technology (Shanghai) Co Ltd Description and Business Overview
6.6.3 Wigen Biomedicine Technology (Shanghai) Co Ltd Exportin 1 Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Wigen Biomedicine Technology (Shanghai) Co Ltd Exportin 1 Product Portfolio
6.6.5 Wigen Biomedicine Technology (Shanghai) Co Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Exportin 1 Industry Chain Analysis
7.2 Exportin 1 Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Exportin 1 Production Mode & Process
7.4 Exportin 1 Sales and Marketing
7.4.1 Exportin 1 Sales Channels
7.4.2 Exportin 1 Distributors
7.5 Exportin 1 Customers
8 Exportin 1 Market Dynamics
8.1 Exportin 1 Industry Trends
8.2 Exportin 1 Market Drivers
8.3 Exportin 1 Market Challenges
8.4 Exportin 1 Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ エキスポーチン1のグローバル市場2023年：染色体領域維持1蛋白質ホモログ、XPO1(Global Exportin 1 Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。

※関連リサーチレポートはありません。


◆H&Iグローバルリサーチのお客様（例）◆